The effects of antiretroviral protease inhibitors on serum lipid levels in HIV-infected patients.
Chang
E S
ES
Division of Allergy and Clinical Immunology, Harbor-UCLA Medical Center, 1000 W Carson St, Box 449, Torrance, CA 90509, USA.
Tetreault
D D
DD
Liu
Y T
YT
Beall
G N
GN
D000273:Adipose Tissue / Q000033:anatomy & histology; D000328:Adult; D000368:Aged; D002784:Cholesterol / Q000097:blood*; D005260:Female; D015658:HIV Infections / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D017320:HIV Protease Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D006949:Hyperlipidemias / Q000139:chemically induced*; D019469:Indinavir / Q000009:adverse effects / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D019888:Nelfinavir / Q000009:adverse effects / Q000627:therapeutic use; D012189:Retrospective Studies; D019438:Ritonavir / Q000009:adverse effects / Q000627:therapeutic use; D019258:Saquinavir / Q000009:adverse effects / Q000627:therapeutic use; D014280:Triglycerides / Q000097:blood*
D017320:HIV Protease Inhibitors; D014280:Triglycerides; D019469:Indinavir; D002784:Cholesterol; D019888:Nelfinavir; D019258:Saquinavir; D019438:Ritonavir